Breaking the Mold: How R is Revolutionizing CSR Generation

There is no doubt that R, a statistical programming language, is gaining popularity in the life sciences sector. By removing costly SAS licensure barriers and tapping into a robust pool of talented R programmers, more biotechs can fund their drug development pipeline and deliver results sooner, benefiting us all.  Read how the FDA and industry innovators are uniting to make CSRs developed using R become the new normal.  

Download

Please fill out this form.

Please enable JavaScript in your browser to complete this form.
Name
Please do not enter personal email id like gmail or yahoo